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Abstract: The dissolution of an antimicrobial ZnO-glass in the form of powder and in the form of
sintered pellets were studied in water, artificial seawater, biological complex media such as common
bacterial/yeast growth media (Luria Bertani (LB), yeast extract, tryptone), and human serum. It has
been established that the media containing amino acids and proteins produce a high lixiviation of
Zn2+ from the glass due to the ability of zinc and zinc oxide to react with amino acids and proteins to
form complex organic compounds. The process of Zn2+ lixiviation from the glass network has been
studied by X-ray photoelectron spectroscopy (XPS). From these results we can state that the process
of lixiviation of Zn2+ from the glass network is similar to the one observed in sodalime glasses, where
Na+ is lixiviated to the media first and the fraction of Zn that acts as modifiers (~2/3) is lixiviated
in second place. After the subsequent collapse of the outer surface glass layer (about 200–300 nm
thick layer) the dissolution process starts again. Antifouling properties against different bacteria
(S. epidermidis, S. aureus, P. aeruginosa, E. coli, and M. lutea) have also been established for the
glass pellets.
Keywords: amino acids; Zn dispenser; biofilm; antimicrobial glass
1. Introduction
Surfaces with antifouling properties to resist the adsorption of microbes are vital in a wide range
of biomedical applications, such as in catheters, prosthetic devices, contact lenses, devices for drug
delivery, or patterned materials for cell culture [1–4]. Zinc oxide nanoparticles [5] are currently used to
functionalize surfaces to investigate their potential ability to reduce biofilm formation on metal and
polymer surfaces [6], medical implants [7], and for their oxidative photocatalytic activity to be used in
waste-water treatment [8].
It is well reported in the literature that dissolution of ZnO metal oxide produces metal ions
(Zn2+) which are known to be responsible for toxicity to bacteria. Consistently, a tight link is found
between the dissolved concentration of metal in solution and the inhibition of bacterial growth [9–21].
The excess absorption of zinc prevents copper and iron absorption by cells, and furthermore Zn2+ acts
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as a strong Lewis acid to the point of being highly corrosive [22]. It has recently been established that
zinc toxicity is strongly dependent on the medium composition. Low ZnO dissolution was observed in
aqueous media (Milli-Q and PBS (Phosphate-buffered saline)) without complex organic components.
Conversely, dissolution about two orders of magnitude higher was detected in media with complex
organic components such as amino acids and proteins (i.e., Luria Bertani (LB) and Tryptic Soy Broth
(TSB)). In this sense ZnO micro/nano-particles can almost be completely dissolved in the mentioned
media instantaneously. Consequently, the physical structure and the ZnO particle morphology can be
strongly affected as well as their interactions with cell membranes and their ability to penetrate into
cells and organisms. Moreover, Li et al. found that the generation of zinc complexes with the organic
compounds from the bacterial growth media reduces the amount of free Zn2+ ions in solution and as a
consequence, cytotoxicity drastically decreases [16].
Considering the complexity as well as the incompletely understood dissolution process of ZnO
particulate and coating systems in the mentioned media in this investigation, instead of a zinc oxide
system we selected a high ZnO content glass (35 wt %) which has been recently developed by the
authors [23]. This glass can be considered chemically stable, non-toxic, and with an excellent activity
(>3 log10 reduction in colony forming-units) against E. coli (Gram-negative), S. aureus (Gram-positive),
and C. krusei (yeast). At a concentration of 2 mg/mL, this glass was also found to be biocompatible
with NIH-3T3 cells (cell viability >80%).
The present work is focused on studying the effect of different simple media (water and
artificial seawater) and biological complex media (Luria Bertani, yeast extract, tryptone, L-glutamine,
and Human Serum) on the kinetics of zinc dissolution of the selected glass. This glass was selected
because of its thermal stability which implies that no devitrification takes place during the sintering
process at 630 ◦C, therefore the glass pellets have the same amorphous structure as the starting powder.
The glass dissolution was determined both for the powder and for the sintered pellets. XPS was used
to study the lixiviation of the Zn ions from the glass network using sintered glass pellets before and
after being immersed in LB for 40 days. The cytotoxicity and antifouling properties of this glass have
also been addressed using sintered glass pellets versus bacteria (S. epidermidis, M. lutea, S. aureus,
P. aeruginosa) and yeast (C. albicans).
2. Materials and Methods
2.1. Preparation of the Glass Powders and Pellets
A zinc-containing glass (d50 = 6.3 ± 0.1 µm) belonging to the B2O3-SiO2-Na2O-ZnO system and
with the following chemical composition (wt %): 19.29% SiO2; 34.24% B2O3; 5.55% Na2O; 5.13% Al2O3
and 34.73% ZnO (labelled as ZnO35), was prepared by the fusion of mixtures of Na2CO3, SiO2, B2O3,
ZnO, and Al2O3 in Pt crucibles at 1250 ◦C for 1 h in an electric furnace. After melting, it was quenched
by dipping the crucible into water, dried, grinded in an agate mortar, and sieved down to 30 µm.
The average particle size of the obtained powder was found to be d50 = 6.3 ± 0.1 µm. The glass
formulation was designed in the miscibility area according to the equilibrium diagram studied by
Taylor et al. [24] and was chosen based on the high antimicrobial activity shown in a previous
study [23]. Al2O3 was added as a stabilizer. The obtained ZnO35 glass powder was subsequently
uniaxially pressed (250 MPa) to obtain green pellets and was then thermally treated for 1 h in air
at 630 ◦C to fabricate dense glass pellets with about 10 mm diameter and 2 mm thickness.
The sintering temperature was selected based on the deformation temperature of these glasses
determined by hot stage microscopy. The ZnO35 pellet after immersion in LB medium is labelled
as ZnO35BIO. As a reference, a non-antimicrobial window glass type pellet named G1 with the
following chemical composition (wt %): 70.2% SiO2, 15.8% Na2O, 7.1% CaO, 3.2% MgO and 1.06%
B2O3, was used.
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2.2. Characterization of the Glass Powders and Pellets
The ZnO35 starting powders were fully characterized by: Nuclear Magnetic Resonance (NMR),
particle size, X-ray diffraction (XRD), Transmission electron microscopy (TEM), Differential thermal
analysis (DTA), and hot stage microscopy in a previous work [23]. The glass pellets were characterized
by X-ray diffraction (XRD) using a Bruker D8 diffractometer with CuK radiation working at 40 kV
and 30 mA in a step-scan spectroscopy. X-ray photoelectron spectroscopy (XPS) measurements
were performed in an ultrahigh vacuum (UHV) chamber with a base pressure of 10−9 mbar using a
hemispherical electron energy analyzer (SPECS Phoibos 150 spectrometer), and non-monochromatized
radiation (Kα 1486.6 eV) from an Al X-ray source operated at 200 W to minimize sample charging
effects. XPS spectra were recorded at a normal emission take-off angle using an energy step and
pass-energy of 0.1 eV and 20 eV for core level spectra and of 0.5 eV and 40 eV for survey scans,
respectively [25]. Samples were irradiated with low energy Ar+ ions for depth profiling experiments.
2.3. Lixiviation of Zn2+
The release of Zn2+ from the zinc containing glasses was evaluated in seven different media:
(i) distilled water; (ii) water containing 3 wt % NaCl (artificial seawater); (iii) Luria Bertani (LB) medium;
(iv) L-Glutamine; (v) Tryptone; (vi) Yeast Extract; and (vii) Human Serum. An aqueous suspension
(5 mg/mL) of ZnO containing glass powder in the corresponding media was kept under agitation at a
constant rate of 120 rpm during 24 h at 37 ◦C. These conditions were kept for all the experiments in the
different media. The analysis of zinc was performed by Inductively Coupled Plasma (ICP) using a
Perkin Elmer optical emission spectrometer model Optima 2100 DV. The solutions analysed by ICP
were previously centrifuged and filtered in order to obtain an aqueous solution containing the metal
ions free of glass particles.
2.4. Biofilm Study
2.4.1. Microorganisms and Growth Conditions
Five bacterial species, including three Gram-positive strains (Staphylococcus epidermidis
ATCC 35984, S. aureus ATCC 29213, and Micrococcus lutea ATCC 9341), two Gram-negative strains
(Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 23389), and the yeast Candida albicans
ATCC 64548, were studied as representative microorganisms involved in biofilm formation on inert
substrates. The selected microorganisms are responsible for >95% of infections related with permanent
devices used in clinical practices. All strains were purchased from American Type Culture Collection
and were strong biofilm producers as determined spectrophotometrically by the crystal violet staining
method [26,27] on polystyrene flat-bottom 96-well microtiter plates (Greiner bio-one, Kremsmünster,
Austria) (data not shown).
Bacterial colonies from a fresh culture on Columbia agar (BD, Becton, Dickinson and Co., Sparks,
MD, USA), were grown overnight in an orbital shaker (100 rpm) at 37 ◦C in Triptic Soya broth (TSB, BD)
supplemented with 50 mM glucose (TSB-glu, Sigma, St. Louis, MI, USA). Cells were harvested, washed
twice in phosphate-buffered saline (PBS, Sigma), and adjusted to a 1 × 107 cell/mL concentration in
TSB-glu. C. albicans were grown in Sabouraud-dextrose agar (BD), propagated overnight at 37 ◦C in
Yeast Nitrogen Base medium (YNB, BD) supplemented with 50 mM glucose (YNB-glu), and adjusted
to 1 × 107 cell/mL concentration.
2.4.2. Biofilm Formation Assays
Biofilms were formed on the surface of the glass pellets using a static in vitro model. Prior to
biofilm production, pellets were autoclaved, incubated in human serum for 12 h, and washed twice
with TSB-glu or YNB-glu. The pellets were incubated in 12-well tissue culture plates (Greiner bio-one)
for 90 min at 37 ◦C with 3 mL of the standardized culture of each microorganism (adhesion phase).
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Pellets were then washed with 5 mL of PBS to remove unattached planktonic cells, placed into new
wells of the culture plates, and incubated for 24 h, 48 h, and 5 days in TSB-glu or YNB-glu.
2.4.3. Biofilm Quantification
After biofilm formation, the pellets were singly placed in 0.3 mL of PBS. Pellets were vigorously
vortexed for 1 min, followed by sonication at 37 KHz (Fisherbrand 15050, Thermo Fisher Scientific,
Waltham, MA, USA) for 10 min and by 1 min of vortexing, to ensure the complete extraction of
the biofilm cells. The suspensions obtained were diluted prior to seeding onto Columbia agar or
Sabouraud-dextrose agar plates, using a spiral platter workstation (Don Whitley Scientific, Shipley,
UK). The plates were incubated for 48 h at 37 ◦C prior to counting colony forming units (CFU). Results
were expressed as CFU/mL. All experiments were performed at least five times.
The antimicrobial effect of ZnO was measured by the reduction in percentage, (R%), of the number
of viable cells recovered from the ZnO35 pellets in comparison to the number of viable cells recovered
from the control G1 pellets after 24 h, 48 h, and 5 days of biofilm development. R% was calculated
using R% = 100 − (100 × IZnO)/IG1, where IZnO is the number of viable counts (CFU/mL) in ZnO35
pellets, and IG1 is the number of viable counts (CFU/mL) in G1 pellets.
2.4.4. Scanning Electron Microscopy (SEM)
S. epidermidis and E. coli biofilms formed on the glass pellets were fixed with a solution of
2.5% glutaraldehyde and 4% paraformaldehyde (Thermo Fisher Scientific). After 1 h of incubation
at room temperature, samples were dehydrated with a graded series of ethanol, immersed in
hexamethyldisilizane, and dried with CO2 in a critical point dryer (Balzers CPD 030, Schalksmühle,
Germany). The specimens were coated with gold/palladium and visualized in a scanning electron
microscope (JEOL JSM 6400; Tokyo, Japan).
2.4.5. Statistical Analysis
Comparisons of cell burdens on G1 or ZnO35 pellets among maturation stages were performed
using analysis of variance (ANOVA) with the Tukey’s test for multiple comparisons (GraphPad Prism
software v. 5.2, San Diego, CA, USA). Comparisons between the number of viable cells recovered from
the G1 and ZnO pellets were explored by using the Student’s t test (two-tailed t-test). A p-value < 0.05
was considered significant.
3. Results and Discussion
3.1. Characterization of the Glass Pellets
The XRD patterns corresponding to the starting glass powders and the subsequently obtained
pellets are shown in Figure 1. The starting glass powders as well as the pellets show the characteristic
bell curve for amorphous glasses with the maximum located at 2θ ~30◦ in both cases.
The XRD band located at ~30◦ may correspond to the most intense XRD diffraction peak (113) of
the Willemite (α-Zn2SiO4) phase (JCPDS file 37-1485) [28].
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Figure 1. XRD patterns of the starting glass powders of ZnO35 and the obtained ZnO35 sintered 
pellets at 630 °C (insert photograph of ZnO35 pellet). 
The XRD band located at ~30° may correspond to the most intense XRD diffraction peak (113) of 
the Willemite (α-Zn2SiO4) phase (JCPDS file 37-1485) [28]. 
3.2. Chemical Stability: Lixiviation of Zn2+ 
The chemical stability in terms of the Zn2+ release from ZnO35 powders and pellets was 
analysed in different media to define their use in biomedical applications such as catheters, stents, 
implanted devices, and prostheses. Both the glass and the powders showed high antimicrobial 
activity against bacterial species and to a lesser extent against yeast as already reported in a previous 
study [23]. In that preliminary study, the non-cytotoxicity of this material was also proven for the 
concentration (5 mg/mL) used in the present investigation. 
Table 1 reports the amount of zinc released from the ZnO35 powder to different media after  
24 h. All biological complex media containing amino acids (LB, yeast extract, L-Glutamine 0.5 wt % 
and Human Serum) produce a high release of Zinc, while the simple media do not significantly 
affect zinc lixiviation which remains very low (~0.5 ppm). It is relevant to point out that these values 
are about two orders of magnitude smaller than the previous ones. 
Table 1. Zn2+ released from the ZnO35 powder to the media after 24 h. 
Medium Zn2+ (ppm) SD
Distillate Water 0.5 0.01 
Water sea-like (3 wt % NaCl) 0.47 0.01 
Luria Bertani (LB) 126.3 0.06 
Yeast Extract (0.5 wt %) 192.681 0.06 
L-Glutamine (0.5 wt %) 386.6 0.06 
Human Serum 248.99 0.05 
The same tendency is observed for the pellets. The lixiviation in distilled water and artificial 
seawater was <1 ppm after 40 days for the ZnO35 pellets (data not shown).  
It is well reported that amino acids and peptides form organic complexes with zinc and zinc 
oxide, resulting in zinc lixiviation. Liu et al. studied the reactions and rates of solubility of ZnO thin 
film coatings exposed to different bacterial growth media [29]. They observed that over a 24 h 
period, 10- to 30-fold higher concentrations of soluble zinc were detected in LB media, relative to 
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3.2. Chemical Stability: Lixiviation of Zn2+
The chemical stability in terms of the Zn2+ release from ZnO35 powders and pellets was analysed
in different media to define their use in biomedical applications such as catheters, stents, implanted
devices, and prostheses. Both the glass and the powders showed high antimicrobial activity against
bacterial species and to a lesser extent against yeast as already reported in a previous study [23].
In that preliminary study, the non-cytotoxicity of this material was also proven for the concentration
(5 mg/mL) used in the present investigation.
Table 1 reports the amount of zinc released from the ZnO35 powder to different media after 24 h.
All biological complex media containing amino acids (LB, yeast extract, L-Glutamine 0.5 wt % and
Human Serum) produce a high release of Zinc, while the simple media do not significantly affect zinc
lixiviation which remains very low (~0.5 ppm). It is relevant to point out that these values are about
two orders of magnitude smaller than the previous ones.
Table 1. Zn2+ released from the ZnO35 powder to the media after 24 h.
Medium Zn2+ (ppm) SD
Distillate Water 0.5 0.01
Water sea-like (3 wt % NaCl) 0.47 0.01
Luria Bertani (LB) 126.3 0.06
Yeast Extract (0.5 wt %) 192.681 0.06
L-Glutamine (0.5 wt %) 386.6 .06
Human Serum 248.99 .05
The same tendency is observed for the pellets. The lixiviation in distilled water and artificial
seawater was <1 ppm after 40 days for the ZnO35 pellets (data not shown).
It is well reported that amino acids and peptides form organic complexes with zinc and zinc
oxide, resulting in zinc lixiviation. Liu et al. studied the reactions and rates of solubility of ZnO thin
film coatings exposed to different bacterial growth media [29]. They observed that over a 24 h period,
10- to 30-fold higher concentrations of soluble zinc were detected in LB media, relative to those not
containing complex organic, PBS, and Milli-Q water. Therefore, zinc lixiviation may be dependent
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on the concentration of amino acids in the media. In order to rationalize this statement and with the
purpose of determining the amount of zinc released from the glass, ZnO35 pellets were introduced
into media containing different concentrations of amino acid L-glutamine (0.05, 0.125 and 0.5 wt %)
for 24 h.
Figure 2 shows almost a linear fit between the L-Glutamine concentration and the Zn2+ release.
These results strongly suggest that the concentration of free amino acids is the factor that determines
the zinc release to the organic media. All biological complex media used in these experiments (Table 1)
were previously sterilized by an autoclave at 120 ◦C for 1 h. Due to the sterilization process, the
proteins contained in these media were partially or even completely disrupted from their former amino
acids, therefore all these media contain a high amount of free amino acids and peptides which explains
the high release of zinc.
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3.3. X-ray Photoelectron Spectroscopy Study 
The XPS experiments have been performed to study the chemical composition of the samples in 
the range of 100 nm upon consecutive cycles of ion bombardment with low energy Ar+ ions of the 
ZnO35 pellet before and after being immersed in LB medium (1 wt % tryptone; 0.5 wt % yeast extract; 
1 wt % NaCl; and 1.5 wt % agar) at 30 °C for 40 days, labelled as ZnO35 and ZnO35BIO, respectively. 
Figure 3 displays a set of Si2p, Zn3p, Al2p, and Na2s core level emissions. Upon analysis of the 
corresponding XPS spectra, a strong reduction in the intensity of both Na2s and Zn2p peaks in the 
ZnO35BIO sample is observed, which reveals a significant depletion of Na and Zn (Figure 3A). It is 
worth mentioning that sodium is a network modifier and, as such, it is expected to be released to the 
medium, considering that the modifiers are the first elements of the glass network to be released [30]. 
In the case of zinc, lixiviation to the media also takes place, but at a lower degree compared to the 
one corresponding to sodium. This result suggests that there are two different types of zinc in the 
glassy matrix network: (i) as a former ion that is kept inside the glass network in tetrahedral 
positions [23] similar to Si4+, B3+, Al3+ and (ii) as a network modifier that is lixiviated as a consequence 
of the presence of high amounts of amino acids in the medium. 
Consecutive ion bombardment cycles with low energy Ar+ ions (1 keV) were carried out to 
obtain in-depth chemical information of the ZnO35 and ZnO35BIO samples. In both cases, the line 
shape and intensity of the XPS spectra resemble steady over ion sputtering steps within the first  
100 nm. The analysis of the XPS spectra evolution shows that the ratios Zn/Si and Na/Si keep 
constant for each sample. A depletion of Na and Zn also exists in the BIO sample that remains stable 
in a 100 nm deep layer while the sample is eroded by ion sputtering. 
Figure 2. Zinc released from the ZnO35 pellet after 24 h in different concentrations of L-Glutamine.
3.3. X-ray Photoelectron Spectroscopy Study
The XPS experiments have been performed to study the chemical composition of the samples in
the range of 100 nm upon consecutive cycles of ion bombardment with low energy Ar+ ions of the
ZnO35 pellet before and after being immersed in LB medium (1 wt % tryptone; 0.5 wt % yeast extract;
1 wt % NaCl; and 1.5 wt % agar) at 30 ◦C for 40 days, labelled as ZnO35 and ZnO35BIO, respectively.
Figure 3 displays a set of Si2p, Zn3p, Al2p, and Na2s core level emissions. Upon analysis of the
corresponding XPS spectra, a strong reduction in the intensity of both Na2s and Zn2p peaks in the
ZnO35BIO sample is observed, which reveals a significant depletion of Na and Zn (Figure 3A). It is
worth mentioning that sodium is a network modifier and, as such, it is expected to be released to the
medium, considering that the modifiers are the first elements of the glass network to be released [30].
In the case of zinc, lixiviation to the media also takes place, but at a lower degree compared to the one
corresponding to sodium. This result suggests that there are two different types of zinc in the glassy
matrix network: (i) as a former ion that is kept inside the glass network in tetrahedral positions [23]
similar to Si4+, B3+, Al3+ and (ii) as a network modifier that is lixiviated as a consequence of the
presence of high amounts of amino acids in the medium.
Consecutive ion bombardment cycles with low energy Ar+ ions (1 keV) were carried out to obtain
in-depth chemical information of the ZnO35 and ZnO35BIO samples. In both cases, the line shape
and intensity of the XPS spectra resemble steady over ion sputtering steps within the first 100 nm.
The analysis of the XPS spectra evolution shows that the ratios Zn/Si and Na/Si keep constant for
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each sample. A depletion of Na and Zn also exists in the BIO sample that remains stable in a 100 nm
deep layer while the sample is eroded by ion sputtering.
In addition, Figure 3B shows the XPS signals normalized to the Si2p peak. A slight difference in
the intensity of the Al2p peak exists which suggests that a small fraction of Al3+ in the tetrahedral
position has been lixiviated with the Na+ as a consequence of its lower stability in the glass network
compared to tetrahedral Si4+.
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Figure 3. X-ray photoelectron spectroscopy (XPS) spectra in the Si2p, Zn3p, Al2p, and Na2s region
of the ZnO35 pellet and the ZnO35 pellet after being immersed for 40 days in LB (labelled as
BIO). (A) XPS signals upon background subtraction; (B) signals normalized to the Si2p peak upon
background subtraction.
In summary, from these results we can state that the process of lixiviation of Zn2+ from the glass
network is similar to the one obseved in sodalime glasses, where Na+ is lixiviated to the media first
and the fraction of Zn acts as a modifier, ~2/3 c n idering the area ratio under the peaks (Figure 3B),
is lixiviated i second place. After the subsequent collapse of t e outer surface glass lay r (about
200–300 nm thick), the disolution process started again [23]. This process is completely different from
the results reported by Liu et al. [29] for zinc oxide thin films, which show that in less than 10 h,
i.e., in LB, the thin film had almost completely dissoved in the media.
On the contrary, in our particular case the glass is an excellent dispenser of Zn2+ to the media for
a very long period of time, in the range of years.
3.4. Antimicrobial Activity
In Figures 4 and 5 the evolution of viable cells within biofilms on control G1 pellets and ZnO35,
respectively, are shown.
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The effect of ZnO35 on the development of bacterial and yeast biofilms was studied. The G1 
pellet composed of a non-antimicrobial window glass [31] was used as a control (Figure 4).  
Despite some interspecies differences in the ability to form biofilms, biofilm cell loads harvested 
from G1 pellets were not significantly different, irrespective of the maturation age of the biofilms:  
24 h, 48 h, or 5 days (Figure 4). The mean number of viable cells within the biofilm for all species 
after 24 h and 5 days of biofilm development ranged from 2.88 × 106 to 2.37 × 108 CFU/mL and from  
2.72 × 106 to 6.30 × 107 CFU/mL, respectively. 
Zinc-containing pellets decreased biofilm formation in comparison to G1 controls. As shown in 
Figure 5, the antibiofilm effect exerted by ZnO35 was species-dependent and increased in a 
time-dependent manner. Reductions in biofilm cell load increased from 24 h to 5 days for all species 
and significantly so for P. aeruginosa (p = 0.006). After 5 days, biofilm burdens of Gram-positive 
bacteria were strongly reduced by 97.1% (p = 0.0011), 99.8% (p = 0.0083), and 96.4% (p = 0.0189) for  
S. epidermidis, M. lutea, and S. aureus, respectively; moderately reduced for E. coli, 71.8%, and  
P. aeruginosa, 61.2%, and virtually not reduced for the yeast, C. albicans. 
The SEM images confirmed biofilm formation and strongly supported the antibiofilm effect of 
ZnO35 (Figure 6). Small clusters of cells, which did not aggregate to form complex biofilm structures 
(panel C), or multilayered cell clusters (panels E and F), were observed to be patchily distributed on 
the surface of ZnO35 pellets instead of multi-layered three-dimensional structures formed on G1 
pellets, after 24 h of biofilm development. As shown in panel 6E, zinc oxide induced cell 
filamentation in E. coli confers certain survival advantages as previously reported by Gunawan et al. [32]. 
Images after 5 days revealed sparsely colonized surfaces by microorganisms (panels D and G), 
abundant cellular debris, and seriously damaged cellular structures (panels D and H). 
Results suggest that the effect is based on the generation of reactive oxygen species (ROS) in all 
of the tested streams, induced by the penetration of ZnO or Zn2+ into the cells. It also agrees with the 
non-cytotoxicity of this material due to the inherent resistances of eukaryotic cells towards oxidative 
stress [13–15,17,19]. According to the conditions tested, it can be stated that the effect of Zn based 
glass is bacteriostatic. However, an increase in the exposition time or a pre-activation of Zn lixiviation 
could lead to a bactericidal effect. 
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The effect of ZnO35 on the development of bacterial and yeast biofilms was studied. The G1 pellet
composed of a non-antimicrobial window glass [31] was used as a control (Figure 4).
Despite some interspecies differences in the ability to form biofilms, biofilm cell loads harvested
from G1 pellets were not significantly different, irrespective of the maturation age of the biofilms:
24 h, 48 h, or 5 days (Figure 4). The mean number of viable cells within the biofilm for all species
after 24 h and 5 days of biofilm development ranged from 2.88 × 106 to 2.37 × 108 CFU/mL and from
2.72 × 106 to 6.30 × 107 CFU/mL, respectively.
Zinc-containing pellets decreased biofilm formation in comparison to G1 controls. As shown
in Figure 5, the antibiofilm effect exerted by ZnO35 was species-dependent and increased in a
time-dependent manner. Reductions in biofilm cell load increased from 24 h to 5 days for all species
and significantly so for P. aeruginosa (p = 0.006). After 5 days, biofilm burdens of Gram-positive bacteria
were strongly reduced by 97.1% (p = 0.0011), 99.8% (p = 0.0083), and 96.4% (p = 0.0189) for S. epidermidis,
M. lutea, and S. aureus, respectively; moderately reduced for E. coli, 71.8%, and P. aeruginosa, 61.2%,
and virtually not reduced for the yeast, C. albicans.
The SEM images confirmed biofilm formation and strongly supported the antibiofilm effect of
ZnO35 (Figure 6). Small clusters of cells, which did not aggregate to form complex biofilm structures
(panel C), or multilayered cell clusters (panels E and F), were observed to be patchily distributed on the
surface of ZnO35 pellets instead of multi-layered three-dimensional structures formed on G1 pellets,
after 24 h of biofilm development. As shown in panel 6E, zinc oxide induced cell filamentation in
E. coli confers certain survival advantages as previously reported by Gunawan et al. [32]. Images after
5 days revealed sparsely colonized surfaces by microorganisms (panels D and G), abundant cellular
debris, and seriously damaged cellular structures (panels D and H).
Results suggest that the effect is based on the generation of reactive oxygen species (ROS) in all of
the tested streams, induced by the penetration of ZnO or Zn2+ into the cells. It also agrees with the
non-cytotoxicity of this material due to the inherent resistances of eukaryotic cells towards oxidative
stress [13–15,17,19]. According to the conditions tested, it can be stated that the effect of Zn based glass
is bacteriostatic. However, an increase in the exposition time or a pre-activation of Zn lixiviation could
lead to a bactericidal effect.
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Considering the results obtained in this study, we can ensure that the glass shows excellent 
multifunctional performances as a bactericide agent and inhibits biofilm formation without 
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(C,D) show colonization f ZnO35 pellets by S. i r idis after 24 h (C) and 5 days (D); (E,F) show
growth of E. coli on ZnO35 surfaces after 24 h, and ( , ) after 5 days.
In previous studies, the cytotoxicity of these glasses was evaluated for both powders and coatings
using NIH-3T cells and the viability was >80% in all cases, which implies no cytotoxicity [23,33].
Consider ng the results obtained in this stu y, w can ensure that the glass shows excellent
multifunctional performances as a bactericide agent and inhibits biofilm formation without cytotoxicity,
which paves the way for major biomedical applications, i.e., dental care. Oral biofilms are strongly
associated to the aetiology of periodontal diseases, dental caries, pulpal diseases, apical periodontitis,
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peri-implant diseases, and candidosis. Furthermore, oral biofilm-associated diseases may affect
systemic health through spreading infections to adjacent tissues and spaces, hematogenously
disseminating oral biofilm bacteria, or inflammatory mechanisms [34]. Controlling coccoid microbiota
growth is a key point to prevent oral biofilm formation and maturation around teeth and dental
implants, since they are the first colonizers. Furthermore, dental caries are caused by Gram-positive
cocci such as Streptococcus mutans and S. sobrinus. ZnO glasses have shown an excellent antibacterial
action against Gram-positive cocci. Coating abutments with ZnO glass or doping dental fillers with
ZnO glass powder would deliver an antimicrobial effect to where it most matters, in order to prevent
oral biofilm formation and dental diseases.
Infections of bare intravascular metal stents are mainly caused by S. aureus. This situation often
leads to emergency surgery with a mortality rate of up to 32.5% (non coronary: 22.9%; and coronary:
48.3%) [35]. A strategy to endow metal stents with antibacterial properties would reduce this major
medical complication and save lives. The results presented in this study show ZnO glass powder and
pellets as good choices for preventing Gram-positive biofilm formation. Metal stents could be coated
with ZnO glasses instead of being bare, but further studies are needed to determine the expansive
properties that the Ni-Ti composition provide to stents with the glass coating mechanical properties.
Periprosthetic joint infection (PJI) is estimated at 1% for hip arthroplasties and ranges between 1%
and 2% for knee arthroplasties; recent data suggest that infection rates might be higher (≥2%) than
previously reported [36,37]. PJI is difficult to cure with antimicrobials and the implant often has to be
removed [37]. Staphylococci (S. aureus and S. epidermidis) are the most frequently reported causes of
PJIs and of concern are PJIs caused by methicillin-resistant strains that result in significant morbidity
and costs for health care delivery [38]. Methicillin-resistance among staphylococci is on rise and the
development of drugs with new mechanisms of action is demanded. A bactericidal effect based on the
ion action of Zn2+ is much more efficient because bacteria cannot develop any mechanism of resistance
towards it. In addition, ZnO glasses have shown a particular bactericidal action against Gram-positive
cocci such as S. aureus. Based on the above-mentioned reasons, coating orthopedic prostheses with
ZnO glass would be a strategy that could decrease patient morbidity and mortality, since it might
prevent periprosthetic infection. Providing arthroplasties with an antibacterial ZnO coating would
also reduce the need of antibiotic consumption and its impact on bacterial ecology.
4. Conclusions
These results suggest that the bacterial growth media strongly affects zinc dissolution from
the glass matrix which has important implications on antibacterial activity and cytotoxicity.
In contrast to ZnO coatings or ZnO micro/nanoparticles, this glass acts as a dispenser of Zn2+ ions
to a media containing monoacids. These glasses have high antifouling properties against bacteria.
As a consequence, this study opens up the future applicability of these glasses in a wide panoply of
biomedical devices (i.e., catheters, stents, dental devices, and prostheses) where antifouling properties
besides biocompatibility are required.
The chemical properties of this glass material and its surface stability are essential to fulfil the
expected performances during exposure to bacteria and during interaction with the BIO media.
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